Chemotherapeutic Drug Implant Patent Filing by CRISM THERAPEUTICS LTD

ChangeBridge: EPO Bulletin - Therapeutics (A61P)

Published March 18th, 2026

Detected March 25th, 2026

Summary

The European Patent Office has published a patent application (EP4548920A2) filed by CRISM THERAPEUTICS LTD for a chemotherapeutic drug implant. The patent application details include the applicant, inventors, and IPC classifications related to drug formulation and administration.

View original document View source feed page

What changed

The European Patent Office has published patent application EP4548920A2, filed by CRISM THERAPEUTICS LTD, concerning a chemotherapeutic drug implant. The publication date is March 18, 2026, and it lists Christopher McConville as an inventor. The application falls under IPC classifications related to medicinal preparations and drug delivery systems.

This filing represents a new intellectual property claim in the pharmaceutical sector. While this is a patent application and not a regulatory rule, it signifies innovation in drug delivery for cancer treatment. Compliance officers in the pharmaceutical industry should be aware of this development as it pertains to potential future products and the competitive landscape.

Source document (simplified)

← EPO Patent Bulletin

CHEMOTHERAPEUTIC DRUG IMPLANT

Publication EP4548920A2 Kind: A2 Mar 18, 2026

Applicants

CRISM THERAPEUTICS LTD

Inventors

MCCONVILLE, Christopher

IPC Classifications

A61K 31/4745 20060101AFI20250703BHEP A61K 9/00 20060101ALI20250703BHEP A61K 47/34 20170101ALI20250703BHEP A61P 35/00 20060101ALI20250703BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →